Login / Signup

Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.

Josanne S de MaarMarianne LuyendijkBritt B M SuelmannDave E W van der KruijssenSjoerd G EliasSabine SieslingElsken van der Wall
Published in: Breast cancer research and treatment (2023)
Differences in clinicopathological characteristics and survival between de novo and metachronous metastatic breast cancer highlight that these are distinct patients groups.
Keyphrases
  • metastatic breast cancer
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • free survival